SCYNEXIS Prices IPO - Quick Facts

(RTTNews) - SCYNEXIS Inc. (SCYX) announced the pricing of its initial public offering of 6.2 million shares of common stock at a public offering price of $10.00 per share, before underwriting discounts and commissions. All of the shares of common stock are being offered by SCYNEXIS. The company's shares are expected to begin trading on The NASDAQ Global Market on May 2, 2014, under the ticker symbol, SCYX.

The company has granted the underwriters a 30-day option to purchase up to an additional 930 thousand shares of common stock at the initial public offering price less the underwriting discounts and commissions to cover over-allotments, if any.

SCYNEXIS is a pharmaceutical company committed to the discovery, development and commercialization of anti-infectives to address significant unmet therapeutic needs.